Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, multi-center, international trial comparing two
reperfusion strategies in elderly (age >= 70 years) patients with acute myocardial
infarction: primary percutaneous coronary intervention (PCI) versus intravenous thrombolytic
therapy. Clinical endpoints will be collected in the hospital, at 1 month, 6 months, and 1
year post-randomization. The primary endpoint is 30 day death or disabling stroke. The study
null hypothesis is that there will be no significant difference in death or disabling stroke
at 30 days post-randomization between patients treated with PCI versus thrombolytics.